What is Scotiabank’s Estimate for Albemarle Q4 Earnings?

Albemarle Co. (NYSE:ALB) – Research analysts at Scotiabank issued their Q4 2024 earnings per share estimates for shares of Albemarle in a research note issued to investors on Monday, November 11th. Scotiabank analyst B. Isaacson anticipates that the specialty chemicals company will post earnings per share of ($0.52) for the quarter. Scotiabank has a “Sector Perform” rating and a $85.00 price target on the stock. The consensus estimate for Albemarle’s current full-year earnings is ($0.52) per share.

ALB has been the topic of a number of other reports. Evercore ISI lowered their price target on shares of Albemarle from $190.00 to $170.00 and set an “outperform” rating on the stock in a research report on Wednesday, August 28th. Deutsche Bank Aktiengesellschaft lowered their target price on shares of Albemarle from $105.00 to $80.00 and set a “hold” rating on the stock in a report on Friday, August 16th. JPMorgan Chase & Co. cut their price target on Albemarle from $115.00 to $78.00 and set a “neutral” rating for the company in a research note on Monday, August 19th. Oppenheimer lowered their price objective on Albemarle from $171.00 to $170.00 and set an “outperform” rating on the stock in a research note on Friday, November 8th. Finally, Robert W. Baird dropped their price objective on Albemarle from $85.00 to $79.00 and set a “neutral” rating for the company in a report on Friday, October 25th. One research analyst has rated the stock with a sell rating, fifteen have given a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $114.47.

Albemarle Stock Up 5.2 %

ALB opened at $108.19 on Wednesday. The stock has a fifty day moving average of $94.60 and a 200-day moving average of $100.20. The company has a market capitalization of $12.72 billion, a P/E ratio of -6.46 and a beta of 1.55. Albemarle has a fifty-two week low of $71.97 and a fifty-two week high of $153.54. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.58 and a current ratio of 2.44.

Albemarle Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, January 2nd. Investors of record on Friday, December 13th will be issued a dividend of $0.405 per share. This represents a $1.62 annualized dividend and a dividend yield of 1.50%. The ex-dividend date of this dividend is Friday, December 13th. Albemarle’s dividend payout ratio (DPR) is -9.67%.

Institutional Trading of Albemarle

Hedge funds have recently made changes to their positions in the company. Primecap Management Co. CA raised its holdings in Albemarle by 0.5% in the 3rd quarter. Primecap Management Co. CA now owns 3,833,984 shares of the specialty chemicals company’s stock valued at $363,117,000 after buying an additional 20,930 shares during the last quarter. Jane Street Group LLC increased its position in Albemarle by 176.6% in the 1st quarter. Jane Street Group LLC now owns 1,588,986 shares of the specialty chemicals company’s stock valued at $209,333,000 after acquiring an additional 3,662,117 shares during the period. ProShare Advisors LLC raised its stake in shares of Albemarle by 10.2% during the second quarter. ProShare Advisors LLC now owns 1,568,602 shares of the specialty chemicals company’s stock valued at $149,833,000 after acquiring an additional 144,705 shares during the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of Albemarle by 2.3% during the second quarter. Dimensional Fund Advisors LP now owns 1,311,331 shares of the specialty chemicals company’s stock worth $125,264,000 after purchasing an additional 29,721 shares during the period. Finally, Earnest Partners LLC grew its stake in shares of Albemarle by 11.9% in the second quarter. Earnest Partners LLC now owns 1,198,730 shares of the specialty chemicals company’s stock worth $114,503,000 after purchasing an additional 127,615 shares during the last quarter. 92.87% of the stock is owned by institutional investors and hedge funds.

About Albemarle

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.